Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2020 August;111(4) > Minerva Medica 2020 August;111(4):366-8

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   Freefree

Minerva Medica 2020 August;111(4):366-8

DOI: 10.23736/S0026-4806.20.06688-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study

Gianni BELCARO 1, 2 , Marcello CORSI 1, 2, Giovanni B. AGUS 3, Maria R. CESARONE 1, 2, Umberto CORNELLI 1, 2, Roberto COTELLESE 1, 2, Beatrice FERAGALLI 1, 2, Shu HU 1, 2

1 Oolex Center for COVID, IRVINE3 Labs, Chieti-Pescara University, Chieti, Italy; 2 Department of Medical and Oral Sciences and Biotechnologies, Chieti-Pescara University, Pescara, Italy; 3 Vascular Surgery University, Milan, Italy



top of page